Insight into the significance of CD8 + tumor‐infiltrating lymphocytes in squamous cell lung cancer
Thoracic Cancer · 2024
DOI: 10.1111/1759-7714.15187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Kazu Shiomi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Although there are great expectations regarding the use of tumor‐infiltrating lymphocytes (TILs) to predict effects of immunotherapies and prognosis, knowledge about TILs remains insufficient for clinical application.
Methods
We objectively investigated the prognostic significance of tumor‐infiltrating CD8 + lymphocytes (CD8 + TILs) in squamous cell lung cancer (SQ‐LC). Among patients who underwent surgical resection of SQ‐LC in 2011–2017, 100 patients with pathological stage IA3‐III were immunohistochemically studied to evaluate CD8 + TILs in the tumor stroma and parenchyma. The impact of CD8 + TILs on relapse‐free survival was analyzed using a Kaplan–Meier survival analysis and multivariate analyses using Fine‐Gray and Cox proportional hazards models.
Results
The multivariate analysis showed that large and small numbers, but not intermediate numbers, of CD8 + TILs in the tumor stroma may be related to a more favorable prognosis (small vs. intermediate: HR, 0.64; 95% CI: 0.29–1.41, p = 0.27; large vs. intermediate: HR, 0.48; 95% CI: 0.21–1.09, p = 0.08). In contrast, a large number of CD8 + TILs in the tumor parenchyma was associated with a poor prognosis (HR, 2.60; 95% CI: 0.91–7.42, p = 0.075). An exploratory analysis showed a potentially strong association between an extremely large number of CD8 + TILs in the tumor parenchyma and a poor prognosis, even with a large number of CD8 + TILs in the tumor stroma.
Conclusion
Our study provided partial but important information on the significance of CD8 + TILs in SQ‐LC. To use CD8 + TILs as biomarkers, a better understanding of CD8 + TILs as well as other important components in the tumor microenvironment and the inflammatory phenotypes they form may be needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan.
- Department of Pathology, Kitasato University School of Medicine, Sagamihara-shi, Japan.
- Department of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
- Department of Biosciences, Kitasato University School of Sciences, Sagamihara-shi, Japan.
- Department of Applied Tumor Pathology, Graduate School of Medical Sciences, Kitasato University, Sagamihara-shi, Japan.
ORCID-Profile: Kazu Shiomi, Dai Sonoda
Zitieren
APA
Shiomi, K., Ichinoe, M., Ushiwata, A., Eshima, K., Nagashio, R., Hayashi, S., Sonoda, D., Kondo, Y., Maruyama, R., Mikubo, M., Murakumo, Y., & Satoh, Y. (2024). Insight into the significance of CD8 + tumor‐infiltrating lymphocytes in squamous cell lung cancer. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15187
Vancouver
Shiomi K, Ichinoe M, Ushiwata A, Eshima K, Nagashio R, Hayashi S, et al. Insight into the significance of CD8 + tumor‐infiltrating lymphocytes in squamous cell lung cancer. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15187
BibTeX
@article{Shiomi2024,
author = {Shiomi, Kazu and Ichinoe, Masaaki and Ushiwata, Ai and Eshima, Koji and Nagashio, Ryo and Hayashi, Shoko and Sonoda, Dai and Kondo, Yasuto and Maruyama, Raito and Mikubo, Masashi and Murakumo, Yoshiki and Satoh, Yukitoshi},
title = {Insight into the significance of CD8 + tumor‐infiltrating lymphocytes in squamous cell lung cancer},
journal = {Thoracic Cancer},
year = {2024},
doi = {10.1111/1759-7714.15187}
}
EUVIMED